An improved method for heterozygote detection of cystinosis, using polymorphonuclear leukocytes
- PMID: 3618595
- PMCID: PMC1684200
An improved method for heterozygote detection of cystinosis, using polymorphonuclear leukocytes
Abstract
Heterozygotes for the autosomal recessive disease cystinosis are currently detected by measuring the cystine content of mixed-leukocyte preparations. The present study was designed to reassess the accuracy of this method and to determine whether measuring the cystine content of purified polymorphonuclear leukocytes would improve heterozygote detection. Blood samples were obtained from 29 obligate heterozygotes for nephropathic cystinosis, one obligate heterozygote for benign cystinosis, and 18 individuals presumed to be normal. When the cystine content of mixed-leukocyte preparations was measured, three heterozygote values overlapped the normal range. When polymorphonuclear-leukocyte cystine content was measured, no heterozygote values were within the normal range. Measurement of the cystine content of purified preparations of polymorphonuclear leukocytes affords a simple method that improves the sensitivity of heterozygote detection for cystinosis.
Similar articles
-
Update on nephropathic cystinosis.Pediatr Nephrol. 1990 Nov;4(6):645-53. doi: 10.1007/BF00858644. Pediatr Nephrol. 1990. PMID: 2088469 Review.
-
Lysosomal cystine counter-transport in heterozygotes for cystinosis.Am J Hum Genet. 1984 Mar;36(2):277-82. Am J Hum Genet. 1984. PMID: 6711558 Free PMC article.
-
High-resolution mapping of the gene for cystinosis, using combined biochemical and linkage analysis.Am J Hum Genet. 1996 Mar;58(3):535-43. Am J Hum Genet. 1996. PMID: 8644713 Free PMC article.
-
Increased cystine in leukocytes from individuals homozygous and heterozygous for cystinosis.Science. 1967 Sep 15;157(3794):1321-2. doi: 10.1126/science.157.3794.1321. Science. 1967. PMID: 6038997
-
The pathogenesis of cystinosis: mechanisms beyond cystine accumulation.Am J Physiol Renal Physiol. 2010 Nov;299(5):F905-16. doi: 10.1152/ajprenal.00318.2010. Epub 2010 Sep 8. Am J Physiol Renal Physiol. 2010. PMID: 20826575 Review.
Cited by
-
Strict cysteamine dose regimen is required to prevent nocturnal cystine accumulation in cystinosis.Pediatr Nephrol. 2006 Jan;21(1):110-3. doi: 10.1007/s00467-005-2052-0. Epub 2005 Oct 27. Pediatr Nephrol. 2006. PMID: 16252107
-
High cystine in platelets from patients with nephropathic cystinosis: a chemical, ultrastructural, and functional evaluation.J Clin Pathol. 2005 Sep;58(9):939-45. doi: 10.1136/jcp.2005.027177. J Clin Pathol. 2005. PMID: 16126874 Free PMC article.
-
Biomarkers in Nephropathic Cystinosis: Current and Future Perspectives.Cells. 2022 Jun 4;11(11):1839. doi: 10.3390/cells11111839. Cells. 2022. PMID: 35681534 Free PMC article. Review.
-
Salla disease variant in a Dutch patient. Potential value of polymorphonuclear leucocytes for heterozygote detection.Eur J Pediatr. 1992 Aug;151(8):590-5. doi: 10.1007/BF01957729. Eur J Pediatr. 1992. PMID: 1505579
-
Update on nephropathic cystinosis.Pediatr Nephrol. 1990 Nov;4(6):645-53. doi: 10.1007/BF00858644. Pediatr Nephrol. 1990. PMID: 2088469 Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources